Trials / Active Not Recruiting
Active Not RecruitingNCT07201883
Chewing Gum vs. Ondansetron as Rescue Treatment for PONV in Female Patients
A Randomized Clinical Trial; Chewing Gum vs. Ondansetron as Rescue Treatment for PONV in Female Patients Undergoing Laparoscopic Surgery at a Single Centre in Lebanon
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Makassed General Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The proposed randomized clinical trial aims to test and compare the efficacy of chewing gum vs. Intravenous antiemetic ondansetron as rescue treatment for post-operative nausea and vomiting (PONV) among Lebanese female patients undergoing laparoscopic surgery in the post-operative anesthesia care unit (PACU).
Detailed description
Post-operative nausea and vomiting remains a significant complication following general anesthesia, particularly when volatile anesthetics are used. Previous studies, including a multicenter randomized trial conducted in Australia, have explored alternative treatment modalities for PONV. Chewing gum, a non-pharmacological intervention, has shown promise as a potential alternative or adjunct to conventional antiemetics like ondansetron. This study focuses on the Lebanese female population, aged 18 and above, who have undergone laparoscopic surgery under volatile anesthetic-based general anesthesia. This demographic is chosen based on established risk factors for PONV and may offer unique insights into efficacy within this subgroup.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ondansetron (Zofran) | 4 mg IV push |
| OTHER | chewing gum | Peppermint sugar free chewing gum |
| COMBINATION_PRODUCT | Ondansetron + Chewing gum | Ondansetron 4 mg IV push Peppermint sugar free chewing gum |
Timeline
- Start date
- 2025-08-22
- Primary completion
- 2026-02-28
- Completion
- 2026-02-28
- First posted
- 2025-10-01
- Last updated
- 2025-10-01
Locations
1 site across 1 country: Lebanon
Source: ClinicalTrials.gov record NCT07201883. Inclusion in this directory is not an endorsement.